ArticleActa pharmaceutica Sinica. B2025

Discovery and proof-of-concept study of a novel highly selective sigma-1 receptor agonist for antipsychotic drug development.

Wanyu Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.